Where the Record Stands The core AOD9604 literature was produced between 1993 and 2015 and has not been followed by additional human clinical trials since the 2007 conclusion of the Metabolic Pharmaceuticals program
Exploring trimethylaminuria: genetics and molecular mechanisms, epidemiology, and emerging therapeutic strategies
When Kojic Acid Makes More Sense When Kojic Acid Makes More Sense Kojic acid may be helpful if you: have localized dark spots want targeted treatment need short-term correction It works on the surface
p38 MAPK, mitogen-activated protein kinases
The patients were 1682 years (mean: 47 years old) without gender preference
[DOI] [PubMed] [Google Scholar] 109.Cholo M.C., Steel H.C., Fourie P.B., Germishuizen W.A., Anderson R